Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Current molecular understanding of Axenfeld-Rieger syndrome.

Författare

Summary, in English

Axenfeld-Rieger syndrome (ARS) is a rare autosomal dominant inherited disorder affecting the development of the eyes, teeth and abdomen. The syndrome is characterised by complete penetrance but variable expressivity. The ocular component of the ARS phenotype has acquired most clinical attention and has been dissected into a spectrum of developmental eye disorders, of which open-angle glaucoma represents the main challenge in terms of treatment. Mutations in several chromosomal loci have been implicated in ARS, including PITX2, FOXC1 and PAX6. Full-spectrum ARS is caused primarily by mutations in the PITX2 gene. The homeobox transcription factor PITX2 is produced as at least four different transcriptional and splicing isoforms, with different biological properties. Intriguingly, PITX2 is also involved in left-right polarity determination, although asymmetry defects are not a feature of ARS. In experimental animal models and in cell culture experiments using PITX2, abundant evidence indicates that a narrow window of expression level of this gene is vital for its correct function.

Publiceringsår

2005

Språk

Engelska

Sidor

1-17

Publikation/Tidskrift/Serie

Expert Reviews in Molecular Medicine

Volym

7

Issue

25

Dokumenttyp

Artikel i tidskrift

Förlag

Cambridge University Press

Ämne

  • Basic Medicine

Nyckelord

  • Rieger
  • Axenfeld–Rieger
  • glaucoma
  • PITX2
  • FOXC1
  • PAX6.

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1462-3994